Senseonics Inc. (SENS)
undefined
undefined%
At close: undefined
0.45
-1.35%
After-hours Dec 13, 2024, 08:00 PM EST

Company Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.

The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.

It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners.

The company has a collaboration agreement with the University Hospitals Accountable Care Organization.

Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Senseonics Inc.
Senseonics  Inc. logo
Country United States
IPO Date Dec 22, 2015
Industry Medical - Devices
Sector Healthcare
Employees 132
CEO Dr. Timothy T. Goodnow Ph.D.

Contact Details

Address:
20451 Seneca Meadows Parkway
Germantown, Maryland
United States
Website https://www.senseonics.com

Stock Details

Ticker Symbol SENS
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001616543
CUSIP Number 81727U105
ISIN Number US81727U1051
Employer ID 47-1210911
SIC Code 3823

Key Executives

Name Position
Dr. Timothy T. Goodnow Ph.D. President, Chief Executive Officer & Director
Dr. Mukul Jain Ph.D. Chief Operating Officer
Dr. Francine Ratner Kaufman M.D. Chief Medical Officer & Director
Kenneth L. Horton J.D. General Counsel & Corporate Development Advisor

Latest SEC Filings

Date Type Title
Dec 12, 2024 4 Filing
Dec 10, 2024 4 Filing
Dec 09, 2024 DEFA14A Filing
Nov 29, 2024 DEF 14A Filing
Nov 27, 2024 S-3 Filing
Nov 19, 2024 8-K Current Report
Nov 19, 2024 PRE 14A Filing
Nov 18, 2024 4 Filing
Nov 18, 2024 4 Filing
Nov 18, 2024 4 Filing